APA (7th ed.) Citation

Mayer, E. F., Falsey, A. R., Clark, R., Ferguson, M., Cardona, J., She, F., . . . Mannan, A. (2025). Safety, Tolerability, and Immunogenicity of mRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18–59 Years. Clinical Infectious Diseases, 81(6), e708. https://doi.org/10.1093/cid/ciaf292

Chicago Style (17th ed.) Citation

Mayer, Erick F., et al. "Safety, Tolerability, and Immunogenicity of MRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18–59 Years." Clinical Infectious Diseases 81, no. 6 (2025): e708. https://doi.org/10.1093/cid/ciaf292.

MLA (9th ed.) Citation

Mayer, Erick F., et al. "Safety, Tolerability, and Immunogenicity of MRNA-1345 in Adults at Increased Risk for Respiratory Syncytial Virus Disease Aged 18–59 Years." Clinical Infectious Diseases, vol. 81, no. 6, 2025, p. e708, https://doi.org/10.1093/cid/ciaf292.